Abstract
The number of renal transplants has been increasing steadily over the last twenty years. This increase has been associated with a significant improvement in the one year graft and patient survival. However, as survival improves, long term complications are becoming more clinically important. We, therefore, retrospectively reviewed our experience of renal transplantation in 165 patients between January 1970 and December 1980, and describe in detail the complications experienced by those whose grafts functioned for 10 years or longer.
The 10 year patient survival rate was 47% and graft survival rate was 30%. The graft survival rate for living related grafts was superior to that of cadaveric grafts. The major cause of mortality in the first year following renal transplantation was infection and in subsequent years, cardiovascular disease predominated. Patients whose grafts functioned for 10 years or more developed a variety of complications including infection, skin cancer and hepatic dysfunction. Clinicians involved in the long term care of the patients need to be aware of these problems and skilled in their management.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mahony, T. J. F., Savdie, E., Caterson, R. J., Furlong, T., Storey, B. G., Stewart, J. H., Sheil, A. G. R. The natural history of cadaveric renal allografts beyond ten years. Transplant Proc. 1986; 18: 135–137.
Gueco, I. P., Evans, D. B., Calne, R. Y. Prolonged survival after renal transplantation: A study of 54 patients who lived ten or more years after operation with functioning allografts. Transplant Proc. 1985; 17: 108–109.
Kaiske, B. L. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am. J. Med. 1988; 84: 985–925.
McGeowan, M. G., Douglas, J. F., Brown, W. A., Donaldson, R. A., Kennedy, J. A., Loughridge, W. G., Mehta, S., Nelson, S. D., Doherty, C. C., Johnstone, R., Todd, G., Hill, C. M. Advantatges of low dose steroid from the day after renal transplantation. Transplantation 1980; 29: 287–289.
Kirkman, R. L., Strom, T. B., Weir, M. R., Tilney, N. L. Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 1982; 34: 345–351.
Conlon, P. J., Walshe, J. J., Smyth, E. G., McNamara, E. B., Donohoe, J., Carmody, M. Irish Journal of Medical Science 1993; 162: 145–7.
Penn, I. Tumours of the immunocompromised patient. Ann. Rev. Med. 1988; 39: 63–73.
Wilkinson, A. H., Smith, J. L., Hunsicker, L. G., Tobacman, J., Kaplelanski, D. P., Johnson, M., Wright, F. H., Behrendt, D. M., Corry, R. J. Increased frequency of post-transplant lymphomas in patients treated with cyclosporine, azathioprine and prednisone. Transplantation 1989; 47: 293–296.
Rao, K. V., Kaiske, B. L., Bloom, P. M. Acute graft rejection in the late survivors of renal transplantation. Clinical and histological observations in the second decade. Transplantation 1989; 47: 290–292.
McGeowan, M., Donaldson, R. A., Kennedy, J. A., Douglas, J. F., Hill, C. M., Loughridge, W. G. G., Middleton, D. Ten-year results of renal transplantation with azathioprine and prednisilone as only immunosuppression. Lancet 1988; 983–985.
Almond, P. S., Matas, A., Gillingham, K., Dunn, D. L., Payne, W. D., Gores, P., Gruessner, R., Majarian, J. S. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752–7.
Hong, J. H., Sumrani, N., Delaney, V., Davis, R., Dibernedetto, A., Butt, K. M. Cause of late renal allograft failure in the ciclosporin era. Nephron. 1992; 62, 272–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Conlon, P.J., Medwar, W., Hanson, S. et al. Long term outcome of renal transplantation in the pre cyclosporin era: One centre’s experience. I.J.M.S. 164, 109–112 (1995). https://doi.org/10.1007/BF02973273
Issue Date:
DOI: https://doi.org/10.1007/BF02973273